For patients who require multisite venous access for catheter ablation procedures, the VASCADE MVP venous vascular closure system (Cardiva Medical) provides a variety of benefits, including a shorter ...
Ed Wagner had been living with varicose veins in his legs for years when he heard about a plan to zap them. Using microwaves emitted from a catheter in the vein, he learned, doctors can close up the ...
Cardiva Medical announced its vascular closure system received an expanded indication in patients undergoing interventional cardiac catheterization procedures and can now be used for femoral venous ...
OKLAHOMA CITY -- Do you find yourself only wanting to wear pants that cover up the ugly veins in your legs? You may be surprised to hear there is somewhat of an easy fix. Dr. Kathylee Santagelo came ...
GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced its development program for PerQseal ® ...
SANTA ROSA — Sapheon Inc., a medical device maker that develops treatments for vascular disease, announced that it has received approval in Europe for its approach to the treatment of varicose veins ...
Vivasure Medical Ltd. has designed a sutureless and absorbable venous vessel closure for use following percutaneous cardiovascular procedures, such as transcatheter mitral valve or tricuspid valve ...
SANTA CLARA, Calif., July 16, 2020 (GLOBE NEWSWIRE) -- Cardiva Medical, Inc., an innovator in the field of vascular closure, today announced the first patient enrollments in its AMBULATE Same Day ...
Austin, June 23, 2025 (GLOBE NEWSWIRE) -- Vascular Closure Devices Market Size & Growth Analysis: According to SNS Insider, the Vascular Closure Devices Market was valued at USD 1.78 billion in 2024 ...
Vivasure Medical Ltd. has designed a sutureless and absorbable venous vessel closure for use following percutaneous cardiovascular procedures, such as transcatheter mitral valve or tricuspid valve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results